January 8, 2025
WASHINGTON, January 8, 2025 – Investors who lost money on securities of Revance Therapeutics, Inc. (“Revance” or the “Company”) (Nasdaq: RVNC) purchased between February 9, 2024 and December 6, 2024 can contact Cohen Milstein Sellers & Toll PLLC to learn about a new class action securities lawsuit.
To learn about your legal options, click here to hear from member of the Cohen Milstein team or contact Partner Molly J. Bowen at (202) 408-4600 or mbowen@cohenmilstein.com.
CASE BACKGROUND: Revance is a biotechnology company that develops and commercializes neuromodulators. A complaint filed on January 3, 2025 in the U.S. District Court for the Middle District of Tennessee alleges that the Company and officers Mark J. Foley and Tobin C. Schilke made false and misleading statements to investors regarding its distribution agreement with Teoxane and a merger agreement with Crown Laboratories, in violation of Section 10(b), Rule 10b-5, and Section 20(a) of the Exchange Act.
NEXT STEPS: If you suffered a significant loss in RVNC shares purchased during the proposed class period of February 9, 2024 to December 6, 2024, and are interested in serving as lead plaintiff in this action, you have until March 4, 2025 to request that the court appoint you as lead plaintiff. You are not required to file a lead plaintiff motion to share in any recovery in this action as a class member.
OUR FIRM: With more than 100 attorneys in eight offices, Cohen Milstein is one of the largest plaintiff-side law firms in the U.S., with more than four decades of experience litigating securities fraud cases. We have recovered billions of dollars to investors, including $1 billion last year as co-lead counsel in In re Wells Fargo & Company Securities Litigation, and are perennially recognized as one of the best securities practice groups in the country by legal publications such as The National Law Journal, Law360, Chambers USA, and The Legal 500. For more information visit www.cohenmilstein.com.
Prior results do not guarantee a similar outcome. This may be considered Attorney Advertising.
CONTACT INFORMATION:
Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Fifth Floor
Washington, D.C. 20005
Telephone: (888) 240-0775 or (202) 408-4600
Email: mbowen@cohenmilstein.com
Website: www.cohenmilstein.com
# # #